Millennium, Compugen In Deal For Protein Pathway Software March 27, 2002 By Rachelle H.B. Fishman No Comments
Ester Neurosciences Gets OK For Myasthenia Gravis Trials Feb. 27, 2002 By Rachelle H.B. Fishman No Comments
Teva’s Copaxone Failure In MS Attributed To Low Relapse Rate Feb. 22, 2002 By Rachelle H.B. Fishman No Comments
Budget Cuts Sidetrack Plan For Israeli Biotech Institute Jan. 9, 2002 By Rachelle H.B. Fishman No Comments
Novartis Enlists Optimata To Analyze New Drug Candidates Jan. 9, 2002 By Rachelle H.B. Fishman No Comments
Mindsense Biosystems Secures $2M For Biomarkers Technology May 23, 2001 By Rachelle H.B. Fishman No Comments
Compugen Contributes Data To Gene Ontology Consortium May 16, 2001 By Rachelle H.B. Fishman No Comments
Israeli Biotech Industry Keeps Going Despite Political Turmoil May 16, 2001 By Rachelle H.B. Fishman No Comments
Clal Biotechnology Establishes Center To Help Israeli Start-Ups March 21, 2001 By Rachelle H.B. Fishman No Comments